# Pharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes Mellitus

> **NCT06964087** · PHASE2 · RECRUITING · sponsor: **Op-T LLC** · enrollment: 72 (estimated)

## Conditions studied

- Type I Diabetes

## Interventions

- **DRUG:** OPT101
- **OTHER:** OPT101 Placebo to Match (PTM)

## Key facts

- **NCT ID:** NCT06964087
- **Lead sponsor:** Op-T LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-10
- **Primary completion:** 2026-05-31
- **Final completion:** 2028-08-19
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2026-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06964087

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06964087, "Pharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes Mellitus". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06964087. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*